Evolving Mechanistic Concepts of Epileptiform Synchronization and their Relevance in Curing Focal Epileptic Disorders.

Epileptiform synchronization anti-epileptic drugs excitatory transmission inhibitory transmission interictal spikes mesial temporal lobe epilepsy seizures voltage-gated channels.

Journal

Current neuropharmacology
ISSN: 1875-6190
Titre abrégé: Curr Neuropharmacol
Pays: United Arab Emirates
ID NLM: 101157239

Informations de publication

Date de publication:
2019
Historique:
received: 25 08 2018
revised: 26 10 2018
accepted: 17 11 2018
pubmed: 28 11 2018
medline: 20 2 2020
entrez: 28 11 2018
Statut: ppublish

Résumé

The synchronized activity of neuronal networks under physiological conditions is mirrored by specific oscillatory patterns of the EEG that are associated with different behavioral states and cognitive functions. Excessive synchronization can, however, lead to focal epileptiform activity characterized by interictal and ictal discharges in epileptic patients and animal models. This review focusses on studies that have addressed epileptiform synchronization in temporal lobe regions by employing in vitro and in vivo recording techniques. First, we consider the role of ionotropic and metabotropic excitatory glutamatergic transmission in seizure generation as well as the paradoxical role of GABAA signaling in initiating and perhaps maintaining focal seizure activity. Second, we address non-synaptic mechanisms (which include voltage-gated ionic currents and gap junctions) in the generation of epileptiform synchronization. For each mechanism, we discuss the actions of antiepileptic drugs that are presumably modulating excitatory or inhibitory signaling and voltage-gated currents to prevent seizures in epileptic patients. These findings provide insights into the mechanisms of seizure initiation and maintenance, thus leading to the development of specific pharmacological treatments for focal epileptic disorders.

Identifiants

pubmed: 30479217
pii: CN-EPUB-94815
doi: 10.2174/1570159X17666181127124803
pmc: PMC7052840
doi:

Substances chimiques

Anticonvulsants 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

830-842

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Références

J Neurosci. 2015 Apr 22;35(16):6600-18
pubmed: 25904809
Hippocampus. 2015 Oct;25(10):1073-188
pubmed: 26135716
Br J Pharmacol. 1993 Mar;108(3):819-23
pubmed: 8467367
J Neurosci. 2000 Sep 15;20(18):6820-9
pubmed: 10995826
Lancet Neurol. 2010 Apr;9(4):413-24
pubmed: 20298965
J Neurosci. 1997 Sep 1;17(17):6729-44
pubmed: 9254685
Exp Brain Res. 1996 Apr;109(1):71-82
pubmed: 8740210
Epilepsia. 2008 Jul;49(7):1160-8
pubmed: 18397292
Epilepsia. 2002 Jul;43(7):685-90
pubmed: 12102669
Neuroscience. 2001;102(2):307-17
pubmed: 11166117
PLoS Biol. 2010 Nov 16;8(11):e1000534
pubmed: 21103408
Front Physiol. 2014 May 07;5:172
pubmed: 24847276
Seizure. 2015 Feb;25:18-25
pubmed: 25645630
Trends Neurosci. 1993 May;16(5):186-92
pubmed: 7685944
Science. 1995 Aug 18;269(5226):977-81
pubmed: 7638623
J Neurosci. 2010 Oct 13;30(41):13679-89
pubmed: 20943908
J Clin Psychiatry. 2005 Nov;66(11):1401-8
pubmed: 16420077
Can J Neurol Sci. 2016 Mar;43(2):219-26
pubmed: 26763167
Exp Neurol. 2013 Oct;248:72-84
pubmed: 23707218
J Neurophysiol. 1997 Apr;77(4):1813-28
pubmed: 9114238
Neuroscience. 2002;114(4):1115-32
pubmed: 12379264
Exp Neurol. 1985 Jul;89(1):250-8
pubmed: 2988992
Adv Pharmacol. 2015;73:167-202
pubmed: 25637441
Neuropharmacology. 2007 Apr;52(5):1291-302
pubmed: 17337018
Nat Commun. 2012;3:1060
pubmed: 22968706
Neuropharmacology. 2017 Nov;126:257-270
pubmed: 28757050
J Neurosci. 1999 Sep 1;19(17):7334-41
pubmed: 10460240
Rev Neurol (Paris). 1997;153 Suppl 1:S39-45
pubmed: 9686247
Epilepsia. 2003 Dec;44(12):1601-4
pubmed: 14636336
Epilepsia. 2009 Mar;50(3):521-36
pubmed: 19178556
J Neurophysiol. 1999 Nov;82(5):2590-601
pubmed: 10561429
Nature. 1977 Sep 22;269(5626):342-4
pubmed: 561893
Mol Pharmacol. 1999 Jun;55(6):1011-9
pubmed: 10347242
Brain Res. 1973 Mar 30;52:1-17
pubmed: 4573428
Science. 1987 Jan 2;235(4784):73-6
pubmed: 2879352
Exp Brain Res. 1991;86(2):248-56
pubmed: 1684548
Biomed Res Int. 2014;2014:282490
pubmed: 25276773
Adv Biochem Psychopharmacol. 1975;(14):113-30
pubmed: 242198
Nat Neurosci. 2002 Aug;5(8):767-74
pubmed: 12118259
J Neurosci. 2014 Dec 10;34(50):16671-87
pubmed: 25505320
J Neurophysiol. 1969 Sep;32(5):663-87
pubmed: 4309022
J Neurophysiol. 1988 May;59(5):1476-96
pubmed: 2898511
J Physiol. 2002 Jun 1;541(Pt 2):521-8
pubmed: 12042356
J Neurophysiol. 1995 Jul;74(1):378-87
pubmed: 7472339
Nat Med. 2016 Dec;22(12):1496-1501
pubmed: 27820603
Mol Pharmacol. 2012 Aug;82(2):199-208
pubmed: 22554805
Ann Neurol. 1991 May;29(5):529-41
pubmed: 1650160
J Neurosci Methods. 2008 Jul 30;172(2):143-57
pubmed: 18550176
Brain Res Mol Brain Res. 1995 Jul;31(1-2):33-47
pubmed: 7476032
Nat Rev Neurosci. 2005 Mar;6(3):191-200
pubmed: 15738956
Mol Pharmacol. 1991 Nov;40(5):756-65
pubmed: 1658608
J Pharmacol Exp Ther. 1989 Jun;249(3):721-5
pubmed: 2543809
J Neurophysiol. 1987 Mar;57(3):869-88
pubmed: 3031235
Exp Brain Res. 1991;84(3):591-8
pubmed: 1650707
Eur J Neurosci. 2007 Dec;26(12):3571-82
pubmed: 18052975
Brain Res. 1980 Feb 3;183(1):61-76
pubmed: 6244050
Science. 1991 Dec 6;254(5037):1515-8
pubmed: 1835799
J Physiol. 1994 May 15;477(Pt 1):35-45
pubmed: 8071887
Biochim Biophys Acta. 2004 Mar 23;1662(1-2):149-58
pubmed: 15033585
Epilepsia. 1995;36 Suppl 6:S7-S9
pubmed: 8595791
J Neurosci. 2004 Oct 6;24(40):8896-906
pubmed: 15470156
Epilepsia. 2011 Jul;52(7):1331-40
pubmed: 21635236
Eur J Neurosci. 2004 May;19(10):2769-78
pubmed: 15147310
Epilepsia. 2006 Sep;47(9):1465-76
pubmed: 16981862
Neuropharmacology. 2017 Jan;112(Pt A):1-3
pubmed: 27659748
Clin Neurophysiol. 2011 Apr;122(4):664-71
pubmed: 21030302
Adv Neurol. 1999;79:685-98
pubmed: 10514855
J Neurophysiol. 1999 Aug;82(2):638-47
pubmed: 10444662
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9665-9
pubmed: 8790388
Brain. 2004 Jul;127(Pt 7):1626-40
pubmed: 15175227
J Neurophysiol. 1969 Sep;32(5):649-62
pubmed: 4309021
Nat Rev Neurosci. 2004 Jul;5(7):553-64
pubmed: 15208697
J Neurosci. 1992 Jan;12(1):104-15
pubmed: 1309571
J Pharmacol Exp Ther. 2002 Dec;303(3):1102-13
pubmed: 12438533
Hippocampus. 1999;9(2):137-42
pubmed: 10226774
Curr Drug Targets CNS Neurol Disord. 2002 Jun;1(3):251-60
pubmed: 12769618
Ann Neurol. 2004 Jul;56(1):108-15
pubmed: 15236407
J Neurosci. 2015 Feb 18;35(7):3048-55
pubmed: 25698742
J Am Med Assoc. 1954 Jan 30;154(5):406-8
pubmed: 13117629
Electroencephalogr Clin Neurophysiol. 1990 Dec;76(6):481-508
pubmed: 1701118
Epilepsy Curr. 2007 Jan-Feb;7(1):15-22
pubmed: 17304346
Clin Chim Acta. 1957 Dec;2(6):481-4
pubmed: 13500579
Neuroscience. 2004;123(2):299-336
pubmed: 14698741
Acta Neurol Scand Suppl. 2013;(197):19-24
pubmed: 23480152
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13644-9
pubmed: 14597722
Nature. 1998 Jul 9;394(6689):189-92
pubmed: 9671303
Epilepsia. 1999 Feb;40(2):127-37
pubmed: 9952257
J Neurophysiol. 1987 Jun;57(6):1911-24
pubmed: 3037040
Neurology. 1992 Apr;42(4):811-5
pubmed: 1314342
Ann Neurol. 2015 Mar;77(3):541-6
pubmed: 25546300
J Neurophysiol. 1997 Apr;77(4):1829-43
pubmed: 9114239
J Physiol. 2010 May 1;588(Pt 9):1527-40
pubmed: 20211979
Brain. 2006 Jun;129(Pt 6):1593-608
pubmed: 16632553
Brain Res Brain Res Rev. 2000 Apr;32(1):235-41
pubmed: 10751673
Epilepsia. 2003 Feb;44(2):150-6
pubmed: 12558567
J Neurosci. 2003 Aug 6;23(18):7069-74
pubmed: 12904467
Eur J Neurosci. 2014 Jan;39(1):46-60
pubmed: 24118191
Neurobiol Dis. 2006 Jun;22(3):496-508
pubmed: 16478664
Neuropharmacology. 2002 Sep;43(4):563-72
pubmed: 12367602
Eur J Neurosci. 1999 Nov;11(11):4110-8
pubmed: 10583499
Epilepsia. 1983 Dec;24(6):703-15
pubmed: 6357772
Neuropharmacology. 2018 Jun;135:424-430
pubmed: 29614316
Eur J Pharmacol. 1996 Jun 20;307(1):113-6
pubmed: 8831112
Ann Neurol. 2008 Dec;64(6):674-86
pubmed: 19107991
Brain Res. 2010 Sep 17;1352:187-99
pubmed: 20599805
J Neurophysiol. 1959 Jul;22(4):436-50
pubmed: 13673295
Pharmacol Biochem Behav. 1983 Jun;18(6):957-66
pubmed: 6351106
Brain Res. 1984 Feb;314(2):243-54
pubmed: 6704751
J Neurosci. 2012 Sep 19;32(38):13264-72
pubmed: 22993442
Prog Neurobiol. 2018 Mar;162:1-16
pubmed: 29197650
Can J Physiol Pharmacol. 1990 Apr;68(4):545-7
pubmed: 2328457
Science. 1981 Jan 16;211(4479):294-7
pubmed: 7444469
Epilepsy Res. 1996 Dec;26(1):141-50
pubmed: 8985696
Exp Neurol. 1991 Feb;111(2):198-203
pubmed: 1846600
Neurobiol Dis. 2011 Jun;42(3):231-41
pubmed: 21238589
J Physiol. 2008 Jan 15;586(2):477-94
pubmed: 17991696
Proc Natl Acad Sci U S A. 2004 Jun 29;101(26):9861-6
pubmed: 15210974
J Neurophysiol. 1993 May;69(5):1541-55
pubmed: 8389828
Epilepsia. 2012 Mar;53(3):459-68
pubmed: 22372627
Cold Spring Harb Perspect Biol. 2011 Aug 01;3(8):a003947
pubmed: 21746798
Prog Neurobiol. 2012 Sep;98(3):241-9
pubmed: 22449727
J Neurophysiol. 1985 Nov;54(5):1363-74
pubmed: 2416891
Neuropharmacology. 2017 Jan;112(Pt A):11-15
pubmed: 27663701
Brain Res. 1990 Mar 19;511(2):280-90
pubmed: 1970748
Annu Rev Physiol. 1996;58:349-62
pubmed: 8815799
Epilepsia. 2009 Jan;50(1):44-55
pubmed: 18637833
J Neurosci. 1996 Jun 15;16(12):3912-24
pubmed: 8656285
Nat Neurosci. 2011 May;14(5):627-34
pubmed: 21460834
Epilepsia. 2004 Jul;45(7):719-28
pubmed: 15230693
Exp Neurol. 1968 Jul;21(3):307-21
pubmed: 5673646
J Neurosci. 2017 Oct 25;37(43):10398-10407
pubmed: 28947576
Epilepsy Curr. 2002 May;2(3):81-85
pubmed: 15309152
Curr Treat Options Neurol. 2005 Jul;7(4):247-259
pubmed: 15967088
J Physiol. 1980 Aug;305:297-313
pubmed: 7441555
Cold Spring Harb Perspect Med. 2016 Jun 01;6(6):
pubmed: 27143702
J Pharmacol Exp Ther. 1995 May;273(2):878-86
pubmed: 7752093
JAMA. 2012 Mar 7;307(9):922-30
pubmed: 22396514
Pol J Pharmacol. 1999 Nov-Dec;51(6):543-5
pubmed: 10817535
Epilepsia. 2005 Aug;46(8):1170-7
pubmed: 16060925
Epilepsy Res Suppl. 1992;8:383-91
pubmed: 1329826
Prog Neurobiol. 1994 Mar;42(4):489-537
pubmed: 7522334
Epilepsy Res. 2007 Dec;77(2-3):157-64
pubmed: 17980555
J Neurophysiol. 1990 Oct;64(4):1077-88
pubmed: 2258736
J Pharmacol Exp Ther. 2009 Aug;330(2):558-66
pubmed: 19417176
Acta Neuropathol. 2001 May;101(5):449-59
pubmed: 11484816
Trends Neurosci. 1988 Feb;11(2):63-8
pubmed: 2465601
Prog Neurobiol. 2011 Oct;95(2):104-32
pubmed: 21802488
Neuron. 2009 Jun 11;62(5):612-32
pubmed: 19524522
J Pharmacol Exp Ther. 1998 Feb;284(2):474-9
pubmed: 9454787
J Neurophysiol. 2004 Aug;92(2):1252-6
pubmed: 15028741
Exp Neurol. 1964 Apr;9:286-304
pubmed: 14145629
Neuroreport. 1996 Jun 17;7(9):1469-74
pubmed: 8856700
Science. 1963 Mar 1;139(3557):840-2
pubmed: 13948714
J Physiol. 1996 Jun 15;493 ( Pt 3):707-17
pubmed: 8799893
Neuron. 2004 Feb 19;41(4):495-511
pubmed: 14980200
Nat Neurosci. 2011 May;14(5):635-41
pubmed: 21441925
Brain Res. 1983 May 9;267(1):101-12
pubmed: 6860937
Neuropharmacology. 2004 Jun;46(8):1097-104
pubmed: 15111016
Neuroscience. 2003;120(1):75-84
pubmed: 12849742
J Neurosci. 1997 Jul 15;17(14):5366-79
pubmed: 9204921
J Neurophysiol. 2015 Mar 1;113(5):1616-30
pubmed: 25505119
Sci Rep. 2017 May 31;7(1):2535
pubmed: 28566726
Science. 1982 May 14;216(4547):745-7
pubmed: 7079735
J Neurophysiol. 2016 Jun 1;115(6):3229-37
pubmed: 27075542

Auteurs

Maxime Lévesque (M)

Montreal Neurological Institute, McGill University, Montreal, H3A 2B4 Quebec, Canada.

David Ragsdale (D)

Montreal Neurological Institute, McGill University, Montreal, H3A 2B4 Quebec, Canada.

Massimo Avoli (M)

Montreal Neurological Institute, McGill University, Montreal, H3A 2B4 Quebec, Canada.
Departments of Neurology & Neurosurgery, and of Physiology, McGill University, Montréal, H3A 2B4 Québec, Canada.
Department of Experimental Medicine, Facoltà di Medicina e Odontoiatria, Sapienza University of Rome, 00185 Roma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH